Table 1.
Characteristics of the 1475 patients in the study.
| Cancer Site | ||||
|---|---|---|---|---|
| Breast n = 531 |
Prostate n = 347 |
Lung n = 298 |
Larynx n = 299 |
|
| Age of diagnosis | ||||
| Years (mean, range) | 57.2 (26–84) | 66.0 (41–84) | 64.1 (43–84) | 61.0 (40–81) |
| Sex | ||||
| Male | 0 | 347 (100%) | 193 (65%) | 254 (85%) |
| Female | 531 (100%) | 0 | 105 (35%) | 45 (15%) |
|
Year of diagnosis (mean, range) |
2011 (2009–2016) | 2013 (2010–2015) | 2011 (2010–2012) | 2013 (2010–2018) |
| Selenium level (µg/L) (mean, range) |
86 (52–172) |
78 (42–138) |
62 (17–108) |
58 (21–105) |
| Zinc level (µg/L) (mean, range) |
867 (525–11045) |
847 (516–1340) |
718 (350–1071) |
640 (358–1318) |
| Copper level (µg/L) (mean, range) |
1153 (685–2153) |
1093 (460–2197) |
1146 (671–2866) |
1116 (436–2795) |
| Years of follow-up (mean) | 9.4 | 7.6 | 6.0 | 6.8 |
| 5- year survival | 85.9% | 83.3% | 45.3% | 63.2% |